Divi's Laboratories Ltd.

DIVISLAB Share PricePharmaceuticals & Drugs

6,426.5

-3.5 (-0.1%)

As on December 12, 2025

Exchange Scrips: BSE532488NSEDIVISLABISININE361B01024

Market Cap1,70,708 Cr

P/E Ratio 77.73

Dividend Yield 0.23 %

Performance

Market performance

Open6,430
High6,519
Volumes1,28,635
Prev6,426.5
Low6,410
As on2025-12-12

Historical performance

1 Year High7,071.5
3 Year High7,071.5
5 Year High7,071.5
1 Year Low4,955
3 Year Low2,730
5 Year Low2,730

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
1,70,708
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
77.73
Dividend Yield
Dividend Yield
0.23 %

Investment Returns

1 Year
8%
3 Years
92.5%
5 Years
76.5%
10 Years
470.8%

Technicals

IndicatorsValueSignal
5-DMA6,354.7Bullish
10-DMA6,401.1Bullish
20-DMA6,427.05Bearish
50-DMA6,457.49Bearish
100-DMA6,315.7Bullish
200-DMA6,257.5Bullish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors249628259819267749280595278893
Government43332

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 77.73.
  • 3Y Stock Price CAGR of the stock is 24.2.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹33210 Million.
  • The company generated revenue of ₹93600 Million in the previous financial year.

Divi's Laboratories Ltd.

6426.5-3.5   (-0.1%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1093555.9
No. of Shares: 170 (Approx)
Performance:9.4%
P/L: ₹93555.9

Top Gainers

SymbolChange%
MAHAPEXLTD95.24(20%)
VIPULLTD10.24(20%)
TVVISION7.77(20%)
TARIL280.2(17%)
WALCHANNAG175.53(14%)

Top Losers

SymbolChange%
REFEX254.9(-20%)
VLSFINANCE299.45(-10%)
BALAXI30.06(-9%)
VLEGOV21.01(-9%)
KSR17.33(-9%)
ASMS12.2(-8%)
VINNY1.28(-7%)
RAJSREESUG37.79(-6%)

Peer Comparison

Venus Remedies Ltd.

53.5%

825.4

1 Month Performance

Nectar Lifesciences Ltd.

48.7%

21.04

1 Month Performance

SMS Pharmaceuticals Ltd.

11.4%

320.7

1 Month Performance

Natco Pharma Ltd.

10.1%

905.65

1 Month Performance

Haleos Labs Ltd.

9.8%

1386.8

1 Month Performance

Ipca Laboratories Ltd.

9.3%

1465.9

1 Month Performance

Zota Health Care Ltd.

9%

1670.2

1 Month Performance

Emcure Pharmaceuticals Ltd.

7.6%

1438.6

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month